Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
Aldeyra Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 25, 2022
Aldeyra Therapeutics reported fiscal year 2021 executive compensation information on April 25, 2022.
In 2021, three executives at Aldeyra Therapeutics received on average a compensation package of $2.2M, a 9% increase compared to previous year.
Average pay of disclosed executives at Aldeyra Therapeutics
Todd C. Brady, Chief Executive Officer, received $3.5M in total, which increased by 43% compared to 2020. 59% of Brady's compensation, or $2.1M, was in option awards. Brady also received $301K in non-equity incentive plan, $547K in salary, $546K in stock awards, as well as $11K in other compensation.
Joshua Reed, Chief Financial Officer, received a compensation package of $1.8M, which increased by 9% compared to previous year. 67% of the compensation package, or $1.2M, was in option awards.
Stephen G. Machatha, Chief Development Officer, earned $1.4M in 2021.
Related executives
You may also like
Source: SEC filing on April 25, 2022.